Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy. Reumatismo [Internet]. 2007 Mar. 30 [cited 2025 Jul. 4];59(1):50-6. Available from: https://www.reumatismo.org/reuma/article/view/reumatismo.2007.50